Essex Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.91M | Sell |
60,810
-892
| -1% | -$101K | 1.26% | 13 |
|
|
2025
Q1 | $6.49M | Sell |
61,702
-3,545
| -5% | -$373K | 1.35% | 11 |
|
|
2024
Q4 | $6.99M | Sell |
65,247
-3,901
| -6% | -$418K | 1.26% | 14 |
|
|
2024
Q3 | $6.92M | Sell |
69,148
-1,632
| -2% | -$163K | 1.21% | 13 |
|
|
2024
Q2 | $5.96M | Buy |
+70,780
| New | +$5.96M | 1.12% | 20 |
|
|
2014
Q3 | – | Sell |
-25,079
| Closed | -$975K | – | 371 |
|
|
2014
Q2 | $975K | Sell |
25,079
-5,045
| -17% | -$196K | 0.14% | 186 |
|
|
2014
Q1 | $1.26M | Sell |
30,124
-10,757
| -26% | -$451K | 0.18% | 170 |
|
|
2013
Q4 | $1.34M | Sell |
40,881
-9,642
| -19% | -$316K | 0.19% | 157 |
|
|
2013
Q3 | $1.36M | Sell |
50,523
-4,463
| -8% | -$120K | 0.21% | 139 |
|
|
2013
Q2 | $1.28M | Buy |
+54,986
| New | +$1.28M | 0.23% | 121 |
|